Jump to Main Content


ASH-EHA Translational Research Training in Hematology

A joint effort of the American Society of Hematology (ASH) and the European Hematology Association (EHA), Translational Research Training in Hematology (TRTH) is a unique, year-long training and mentoring program focused on helping early stage researchers, including senior postdoctoral fellows and junior faculty, gain the tools necessary to build successful careers in blood-related translational research.

Each year, 20 early-career scientists (10 from North America and 10 from Europe) are selected to participate in the prestigious and rigorous training program led by faculty who are international leaders in hematology. Topics covered include biostatistics and biomarkers, genetics and molecular biology, ethics, and phase I clinical study design.

Learn more

Learn more about previous TRTH Award recipients.

Key Dates

March 22 - June 15, 2023 Call open - LOI application
Early December 2023 Formal acceptance procedure
March 8 - March 15, 2024 Spring course

Corporate Support

ASH receives support for TRTH from: Astellas Pharma, Bristol-Myers Squibb, Gilead Sciences, Inc., and Takeda Oncology.

For information about supporting the award, visit ASH's Corporate Support page or contact [email protected].


For more information, please contact the EHA Executive Office at [email protected].